For: | Li Z, Ding Q, Ling LP, Wu Y, Meng DX, Li X, Zhang CQ. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells in vivo and in vitro by activating AMP-activated protein kinase. World J Gastroenterol 2018; 24(7): 819-832 [PMID: 29467552 DOI: 10.3748/wjg.v24.i7.819] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v24/i7/819.htm |
Number | Citing Articles |
1 |
Can-Xiang Lin, Yan Li, Shi Liang, Jun Tao, Li-Sui Zhang, Yang-Fan Su, Yun-Xi Huang, Zong-Kai Zhao, Shan-Ying Liu, Jun-Meng Zheng. Metformin Attenuates Cyclosporine A-induced Renal Fibrosis in Rats. Transplantation 2019; 103(10): e285 doi: 10.1097/TP.0000000000002864
|
2 |
Devaraj Ezhilarasan. Mitochondria: A critical hub for hepatic stellate cells activation during chronic liver diseases. Hepatobiliary & Pancreatic Diseases International 2021; 20(4): 315 doi: 10.1016/j.hbpd.2021.04.010
|
3 |
Ying Su, Shan Lu, Kehan Ren, Meili Wang, Chenjian Hou, Xiaoli Liu, Shanyu Zhao, Xiu-Ping Liu. Alleviation of Liver Fibrosis Via Hepatic Stellate Cells Mitochondrial Apoptosis Induced by Metformin. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3990740
|
4 |
K. V. Derkach, I. V. Romanova, I. I. Zorina, A. A. Bakhtyukov, A. A. Perminova, A. O. Ivantsov, A. O. Shpakov. Effect of High-Dose Metformin on the Metabolic Parameters and Functional State of the Liver of Agouti Mice with Melanocortin Obesity. Advances in Gerontology 2020; 10(1): 13 doi: 10.1134/S2079057020010038
|
5 |
Wei Hou, Wing-Kin Syn. Role of Metabolism in Hepatic Stellate Cell Activation and Fibrogenesis. Frontiers in Cell and Developmental Biology 2018; 6 doi: 10.3389/fcell.2018.00150
|
6 |
Peter C. Hart, Tatsuyuki Chiyoda, Xiaojing Liu, Melanie Weigert, Marion Curtis, Chun-Yi Chiang, Rachel Loth, Ricardo Lastra, Stephanie M. McGregor, Jason W. Locasale, Ernst Lengyel, Iris L. Romero. SPHK1 Is a Novel Target of Metformin in Ovarian Cancer. Molecular Cancer Research 2019; 17(4): 870 doi: 10.1158/1541-7786.MCR-18-0409
|
7 |
Z.M.M. Omar, A.A.-N. Ahmed, M.H. El-Bakry, M.A. Ahmed, A. Hasan. Metformin versus silymarin as hepatoprotective agents in mice fibrotic model caused by carbon tetrachloride. Annales Pharmaceutiques Françaises 2022; 80(5): 659 doi: 10.1016/j.pharma.2022.01.005
|
8 |
Dongxiao Meng, Zhen Li, Guangchuan Wang, Liping Ling, Ying Wu, Chunqing Zhang. Carvedilol attenuates liver fibrosis by suppressing autophagy and promoting apoptosis in hepatic stellate cells. Biomedicine & Pharmacotherapy 2018; 108: 1617 doi: 10.1016/j.biopha.2018.10.005
|
9 |
Edward F. Xie, Bingqing Xie, Urooba Nadeem, Mark D'Souza, Gonnah Reem, Dinanath Sulakhe, Dimitra Skondra. Using Advanced Bioinformatics Tools to Identify Novel Therapeutic Candidates for Proliferative Vitreoretinopathy. Translational Vision Science & Technology 2023; 12(5): 19 doi: 10.1167/tvst.12.5.19
|
10 |
Amirhossein Malaekeh-Nikouei, Sina Shokri-Naei, Sobhan Karbasforoushan, Hossein Bahari, Vafa Baradaran Rahimi, Reza Heidari, Vahid Reza Askari. Metformin beyond an anti-diabetic agent: A comprehensive and mechanistic review on its effects against natural and chemical toxins. Biomedicine & Pharmacotherapy 2023; 165: 115263 doi: 10.1016/j.biopha.2023.115263
|
11 |
Kira Derkach, Irina Zakharova, Inna Zorina, Andrey Bakhtyukov, Irina Romanova, Liubov Bayunova, Alexander Shpakov, Guillermo López Lluch. The evidence of metabolic-improving effect of metformin in Ay/a mice with genetically-induced melanocortin obesity and the contribution of hypothalamic mechanisms to this effect. PLOS ONE 2019; 14(3): e0213779 doi: 10.1371/journal.pone.0213779
|
12 |
Pearlin Hameed, Geetha Manivasagam. An overview of bio-actuation in collagen hydrogels: a mechanobiological phenomenon. Biophysical Reviews 2021; 13(3): 387 doi: 10.1007/s12551-021-00804-x
|
13 |
Tao Yang, Qijie Guan, Jin-Song Shi, Zheng-Hong Xu, Yan Geng. Metformin alleviates liver fibrosis in mice by enriching Lactobacillus sp. MF-1 in the gut microbiota. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2023; 1869(5): 166664 doi: 10.1016/j.bbadis.2023.166664
|
14 |
Zhaohua Yang, Jinying Wei, Yashu Wang, Yunxia Du, Shan Song, Jiawei Li, Ziyuan Su, Yonghong Shi, Haijiang Wu. Irisin Ameliorates Renal Tubulointerstitial Fibrosis by Regulating the Smad4/β-Catenin Pathway in Diabetic Mice. Diabetes, Metabolic Syndrome and Obesity 2023; : 1577 doi: 10.2147/DMSO.S407734
|
15 |
Ying Su, Shan Lu, Chenjian Hou, Kehan Ren, Meili Wang, Xiaoli Liu, Shanyu Zhao, Xiuping Liu. Mitigation of liver fibrosis via hepatic stellate cells mitochondrial apoptosis induced by metformin. International Immunopharmacology 2022; 108: 108683 doi: 10.1016/j.intimp.2022.108683
|
16 |
Belén G. Sánchez, Alicia Bort, Diana Vara-Ciruelos, Inés Díaz-Laviada. Androgen Deprivation Induces Reprogramming of Prostate Cancer Cells to Stem-Like Cells. Cells 2020; 9(6): 1441 doi: 10.3390/cells9061441
|
17 |
Cornel Balta, Hildegard Herman, Alina Ciceu, Caterina Claudia Lepre, Bianca Mladin, Marcel Rosu, Daniela Oatis, Marina Russo, Victor Eduard Peteu, Mihaela Gherghiceanu, Ferenc Fenyvesi, Coralia Cotoraci, Maria Consiglia Trotta, Michele D’Amico, Anca Hermenean. Chrysin-loaded calixarene-cyclodextrin ternary drug delivery system inhibits TGF-β and galectin-1 mediated pathways in diabetic liver fibrosis. Biochemical Pharmacology 2024; 229: 116474 doi: 10.1016/j.bcp.2024.116474
|
18 |
Julieta Afonso, Lúcio L. Santos, Adhemar Longatto-Filho, Fátima Baltazar. Competitive glucose metabolism as a target to boost bladder cancer immunotherapy. Nature Reviews Urology 2020; 17(2): 77 doi: 10.1038/s41585-019-0263-6
|
19 |
Ying Wu, Xue Ge, Si-Ning Wang, Chun-Qing Zhang, Koichiro Wada. Olmesartan Improves Hepatic Sinusoidal Remodeling in Mice with Carbon Tetrachloride-Induced Liver Fibrosis. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/4710993
|
20 |
Gang Wang, Fang Lin, Qin Wan, Jianbo Wu, Mao Luo. Mechanisms of action of metformin and its regulatory effect on microRNAs related to angiogenesis. Pharmacological Research 2021; 164: 105390 doi: 10.1016/j.phrs.2020.105390
|
21 |
Gaoyi Ruan, Fangquan Wu, Dibang Shi, Hongxia Sun, Fangyan Wang, Changlong Xu. Metformin: update on mechanisms of action on liver diseases. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1327814
|
22 |
Bixi Tang, Can Jin, Maoting Li, Siqi Liu, Xuemei Zhang, Jia Li, Kan Ding, Yi Zang. A novel pectin-like polysaccharide from Crocus sativus targets Galectin-3 to inhibit hepatic stellate cells activation and liver fibrosis. Carbohydrate Polymers 2025; 348: 122826 doi: 10.1016/j.carbpol.2024.122826
|
23 |
Maoyan Wu, Huiwen Xu, Jingyu Liu, Xiaozhen Tan, Shengrong Wan, Man Guo, Yang Long, Yong Xu, Akira Sugawara. Metformin and Fibrosis: A Review of Existing Evidence and Mechanisms. Journal of Diabetes Research 2021; 2021: 1 doi: 10.1155/2021/6673525
|
24 |
Mohammed Attieh Alzahrani, Hasnaa Ali Ebrahim, Aida Sanad Alqarni, Fahaid Hassan Al-Hashem. Metformin and Resveratrol Suppress Oxidative Stress/Hypoxia Axis Associated with the Amelioration of Thioacetamide-Induced Liver Injury. International Journal of Pharmacology 2023; 19(3): 439 doi: 10.3923/ijp.2023.439.446
|
25 |
Ying Wu, Ai-Hong Yin, Jun-Tao Sun, Wei-Hua Xu, Chun-Qing Zhang. Angiotensin-converting enzyme 2 improves liver fibrosis in mice by regulating autophagy of hepatic stellate cells. World Journal of Gastroenterology 2023; 29(33): 4975-4990 doi: 10.3748/wjg.v29.i33.4975
Abstract(584) |
Core Tip(489) |
Full Article(HTML)(2097)
|
Full Article with Cover (PDF)-21592K(128)
|
Full Article (Word)-6178K(62)
|
Audio-10227K(5)
|
Peer-Review Report-240K(61)
|
Answering Reviewers-192K(58)
|
Full Article (PDF)-20840K(199)
|
Full Article (XML)-460K(61)
|
Times Cited (4)
|
Total Visits (5793)
|
Open
|
26 |
Chien-Yu Lin, Pratik Adhikary, Kun Cheng. Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis. Advanced Drug Delivery Reviews 2021; 174: 127 doi: 10.1016/j.addr.2021.04.008
|
27 |
Fengzhen Wang, Haihan Sun, Bangjie Zuo, Kun Shi, Xin Zhang, Chi Zhang, Dong Sun. Metformin attenuates renal tubulointerstitial fibrosis via upgrading autophagy in the early stage of diabetic nephropathy. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-95827-5
|
28 |
Changfeng Shan, Ronghua Wang, Shuai Wang, Zongmeng Zhang, Chaofeng Xing, Wenbin Feng, Zhenggang Zhao, Sujin Zhou, Allan Zijian Zhao, Yunping Mu, Fanghong Li. Endogenous production of n−3 polyunsaturated fatty acids protects mice from carbon tetrachloride‐induced liver fibrosis by regulating mTOR and Bcl‐2/Bax signalling pathways. Experimental Physiology 2021; 106(4): 983 doi: 10.1113/EP089328
|
29 |
Rubinder Basson, Ardeshir Bayat. Wound Healing, Tissue Repair, and Regeneration in Diabetes. 2020; : 121 doi: 10.1016/B978-0-12-816413-6.00007-1
|
30 |
Federica Perazza, Laura Leoni, Santo Colosimo, Alessandra Musio, Giulia Bocedi, Michela D’Avino, Giulio Agnelli, Alba Nicastri, Chiara Rossetti, Federica Sacilotto, Giulio Marchesini, Maria Letizia Petroni, Federico Ravaioli. Metformin and the Liver: Unlocking the Full Therapeutic Potential. Metabolites 2024; 14(4): 186 doi: 10.3390/metabo14040186
|
31 |
Lin Jia, Yang Yang, Feng Sun, Hui Tao, Chao Lu, Jing-Jing Yang. Mitochondrial quality control in liver fibrosis: Epigenetic hallmarks and therapeutic strategies. Cellular Signalling 2024; 115: 111035 doi: 10.1016/j.cellsig.2024.111035
|
32 |
Youtian Zhang, Long Ren, Yinting Tian, Xiaohu Guo, Fengxian Wei, Yawu Zhang. Signaling pathways that activate hepatic stellate cells during liver fibrosis. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1454980
|
33 |
Andrés Tabernilla, Bruna dos Santos Rodrigues, Alanah Pieters, Anne Caufriez, Kaat Leroy, Raf Van Campenhout, Axelle Cooreman, Ana Rita Gomes, Emma Arnesdotter, Eva Gijbels, Mathieu Vinken. In Vitro Liver Toxicity Testing of Chemicals: A Pragmatic Approach. International Journal of Molecular Sciences 2021; 22(9): 5038 doi: 10.3390/ijms22095038
|
34 |
Fahaid Al‐Hashem, Suliman Al‐Humayed, Shaimaa N. Amin, Samaa S. Kamar, Soheir S. Mansy, Sarah Hassan, Lubna O. Abdel‐Salam, Mohamed Abd Ellatif, Mohammed Alfaifi, Mohamed A. Haidara, Bahjat Al‐Ani. Metformin inhibits mTOR–HIF‐1α axis and profibrogenic and inflammatory biomarkers in thioacetamide‐induced hepatic tissue alterations. Journal of Cellular Physiology 2019; 234(6): 9328 doi: 10.1002/jcp.27616
|
35 |
Xuecui Yin, Lin Dong, Xiaohan Wang, Zhenzhen Qin, Yuying Ma, Xiaofei Ke, Ya Li, Qingde Wang, Yang Mi, Quanjun Lyu, Xia Xu, Pengyuan Zheng, Youcai Tang. Perilipin 5 regulates hepatic stellate cell activation and high‐fat diet‐induced non‐alcoholic fatty liver disease. Animal Models and Experimental Medicine 2024; 7(2): 166 doi: 10.1002/ame2.12327
|
36 |
Jia Huang, Tian Tu, Wenbo Wang, Zhen Gao, Guangdong Zhou, Wenjie Zhang, Xiaoli Wu, Wei Liu. Aligned topography mediated cell elongation reverses pathological phenotype of in vitro cultured keloid fibroblasts. Journal of Biomedical Materials Research Part A 2019; 107(7): 1366 doi: 10.1002/jbm.a.36650
|
37 |
Anqi Zhang, Fangyi Qian, Yangyang Li, Bowen Li, Furong Yang, Chengmu Hu, Wuyi Sun, Yan Huang. Research progress of metformin in the treatment of liver fibrosis. International Immunopharmacology 2023; 116: 109738 doi: 10.1016/j.intimp.2023.109738
|
38 |
Jing Yang, Suxin Li, Shengyan Liu, Yuehui Zhang, Dongqi Shen, Peiju Wang, Xiaowei Dang. Metformin ameliorates liver fibrosis induced by congestive hepatopathy via the mTOR/HIF-1α signaling pathway. Annals of Hepatology 2023; 28(6): 101135 doi: 10.1016/j.aohep.2023.101135
|
39 |
Xu Li, Yuan Jiao, Yunlong Xing, Pujun Gao. Diabetes Mellitus and Risk of Hepatic Fibrosis/Cirrhosis. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/5308308
|